Therapeutic Substances Regulations (Amendment) (Cth)

STATUTORY RULES.

1961. No.49.

 

REGULATIONS UNDER THE THERAPEUTIC SUBSTANCES ACT 1953-1959.*

I, THE ADMINISTRATOR of the Government of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Therapeutic Substances Act 1953-1959.

Dated this 23rd day of March, 1961.

DALLAS BROOKS

Administrator.

By His Excellency’s Command,

 

(Sgd.) Donald A. Cameron

Minister of State for Health.

 

AMENDMENTS OF THE THERAPEUTIC SUBSTANCES REGULATIONS. 

Payment for samples.

1. Regulation 16 of the Therapeutic Substances Regulations is amended—

(a) by omitting the words “and the goods taken as the sample conform to the standard for those goods”; and

(b) by adding at the end thereof the following sub-regulation:—

“(2.) Payment shall not be made under the last preceding sub-regulation for a sample of goods if there is, for the purposes of the Act, a standard for those goods and the goods taken as the sample do not conform to that standard.”.

Biological Products Standards Committee.

2. Regulation 20 of the Therapeutic Substances Regulations is repealed and the following regulation inserted in its stead:—

“20.—(1.) There shall be a committee to be known as the Biological Products Standards Committee.

“(2.) The Committee shall consist of—

(a) the Director-General;

(b) the Director of the National Biological Standards Laboratory;

(c) a person who is an expert in virology;

(d) a person who is an expert in medical bacteriology;

(e) a person who is an expert in veterinary bacteriology;

(f) a person who is an expert in endocrinology; and

(g) a person who is an expert in epidemiology.

“(3.) The members of the Committee, other than the members referred to in paragraphs (a) and (b) the last preceding sub-regulation, shall be appointed by the Minister.

 

* Notified in the Commonwealth Gazette on 29th March, 1961.

  Statutory Rules 1956, No. 4, as amended by Statutory Rules 1956, No. 113; 1957, No. 64; 1958, No. 21; and 1959, No. 14.

8900/60.—PRICE 3D. 10/8.2.1961.

 

“(4.) If the Minister becomes aware that a member of the Committee appointed by him will be unable to attend a meeting or meetings of the Committee, the Minister may appoint a person who has the same qualifications as the member to act instead of that member at the meeting or meetings from which he will be absent, and the person so appointed shall, while so acting, be deemed to be a member of the Committee.

“(5.) The functions of the Committee are to inquire into, and advise the Minister on, the standards, and matters relating to the standards, of antibiotics, antigens, antitoxins, blood derivatives, insulin products, sera, toxoids, vaccines and other biological products.

“(6.) The Committee may appoint a sub-committee consisting of such members of the Committee and such other persons (if any) as the Committee thinks fit for the purpose of inquiring into, and reporting to the Committee on, any matter that is within the functions of the Committee.”.

Therapeutic Substances Standards Committee.

3. Regulation 21 of the Therapeutic Substances Regulations is amended—

(a) by omitting paragraph (b) of sub-regulation (2.) and inserting in its stead the following paragraph:—

“(b) the Director of the National Biological Standards Laboratory;”;

(b) by omitting paragraph (d) of sub-regulation (2.) and inserting in its stead the following paragraph:—

“(d) two persons, each of whom is an expert in Pharmacology or Pharmaceutical Chemistry, appointed by the Minister;”;

(c) by inserting after sub-regulation (2.) the following sub-regulation:—

“(2A.) If the Minister becomes aware that a member of the Committee appointed by him will be unable to attend a meeting or meetings of the Committee, the Minister may appoint a person who has the same qualifications as the member to1 act instead of that member at the meeting or meetings from which he will be absent, and the person so appointed shall, while so acting, be deemed to be a member of the Committee.”; and

(d) by adding at the end thereof the following sub-regulation:—

“(5.) The Committee may appoint a sub-committee consisting of such members of the Committee and such other persons (if any) as the Committee thinks fit for the purpose of inquiring into, and reporting to the Committee on, any matter that is within the functions of the Committee.”.

Chairman and Secretary of Committees.

4. Regulation 22 of the Therapeutic Substances Regulations is amended by omitting sub-regulation (1.) and inserting in its stead the following sub-regulation:—

“(1.) Subject to the next succeeding sub-regulation, the chairman of a Committee shall be the Director-General and the Secretary of a Committee shall be an officer of the Department of Health appointed by the Director-General.”.

 

By Authority: A. J. ARTHUR, Commonwealth Government Printer, Canberra.